Page 77 - UCT2012 Health Sciences

Basic HTML Version

Health Sciences
Alvarez, G.G., Sabri, E., Ling, D., Cameron, D.W., Maartens,
G. and Wilson, D. 2012. A model to rule out smear-negative
tuberculosis among symptomatic HIV patients using
C-reactive protein. International Journal of Tuberculosis
and Lung Disease, 16(9): 1247-1251.
Aminake, M.N., Mahajan, A., Kumar, V., Hans, R.H., Wiesner,
L., Taylor, D., De Kock, C., Grobler, A., Smith, P.J., Kirschner,
M., Rethwilm, A., Pradel, G. and Chibale, K. 2012. Synthesis
and evaluation of hybrid drugs for a potential HIV/AIDS-
malaria combination therapy. Bioorganic & Medicinal
Chemistry, 20: 5277-5289.
Anderson, P.L., Glidden, D.V., Liu, A., Buchbinder, S.P.,
Lama, J.R., Guanira, J.V., McMahan, V., Bushman, L.R.,
Casapia, M., Montoya-Herrera, O., Veloso, V.G., Mayer, K.H.,
Chariyalertsak, S., Schechter, M., Bekker, L., Kallas, E.G. and
Grant, R. 2012. Emtricitabine-tenofovir concentrations and
pre-exposure prophylaxis efficacy in men who have sex
with men. Science Translational Medicine, 4(151): 1-8.
Andrews, J.R., Wood, R., Bekker, L., Middelkoop, K. and
Walensky, R.P. 2012. Projecting the benefits of antiretroviral
therapy for HIV prevention: the impact of population
mobility and linkage to care. Journal of Infectious Diseases,
206: 543-551.
Andrews, J.R., Lawn, S.D., Rusu, C., Wood, R., Noubary,
F., Bender, M., Horsburgh, C.R., Losina, E., Freedberg,
K.A. and Walensky, R.P. 2012. The cost-effectiveness of
routinne tuberculosis screening with xpert MTB/RIF prior to
initiation of antiretroviral therapy: a model-based analysis.
AIDS, 26: 987-995.
Arentz, M., Pavlinac, P., Kimerling, M.E., Horne, D.J.,
Falzone, D., Schunemann, H.J., Royce, S., Dheda, K.
and Walson, J.L. 2012. Use of anti-retroviral therapy in
tuberculosis patients on second-line anti-TB regimens: a
systematic review. PLoS One, 7(11): e47370.
Ataher, Q., Portsmouth, S., Napolitano, L., Eng, S.,
Greenacre, A., Kambugu, A., Wood, R., Badal-Faesen,
S. and Tressler, R. 2012. The epidemiology and clinical
correlates of HIV-1 co-receptor tropism in non-subtype B
infections from India, Uganda and South Africa. Journal of
the International AIDS Society, 15:2.
Bateman, E.D., Bleecker, E.R., Lotvall, J., Woodcock, A.,
Forth, R., Medley, H., Davis, A.M., Jacques, L., Haumann, B.
and Busse, W. 2012. Dose effect of once-daily fluticasone
furoate in persistent asthma: a randomized trial. Respiratory
Medicine, 106: 642-650.
Bateman, E.D., Feldman, G., Kilbride, S., Brooks, J., Mehta,
R., Harris, S., Maden, C. and Crater, G. 2012. Efficacy and
safety of the long-acting muscarinic antagonist GSK233705
delivered once daily in patients with COPD. Clinical
Respiratory Journal, 6: 248-257.
Beach, R.A., Wilkinson, K., Gumedze, F.N. and Khumalo, N.
2012. Baseline sebum IL-1
is higher than expected in afro-
textured hair: a risk factor for hair loss? Journal of Cosmetic
Dermatology, 11: 9-16.
Beach, R.A., Wilkinson, K., Gumedze, F.N. and Khumalo,
N.P. 2012. Sebum transforming growth factor B1 induced
by Hair Products. Archives of Dermatology, 148(6): 764-766.
Benatar, S.R. and Benatar, D. 2012. From medical manners
to moral reasoning: an historical overview of bioethics in
the University of Cape Town’s Faculty of Health Sciences.
SAMJ South African Medical Journal, 102(6): 406-408.
Benjamin, L.A., Bryer, A., Emsley, H.C.A., Khoo, S., Solomon,
T. and Connor, M.D. 2012. HIV infection and stroke: current
perspectives and future directions. Lancet Neurology, 11:
Bertram, M.Y., Steyn, K., Wentzel-Viljoen, E., Tollman, S.M.
and Hofman, K.J. 2012. Reducing the sodium content of
high-salt foods: effect on cardiovascular disease in South
Africa. SAMJ South African Medical Journal, 102(9): 743-745.
Besana, A., Wang, D.W., George Jr, A.L. and Schwartz, P.J.
2012. Nadolol block of nav1.5 does not explain its efficacy
in the long QT syndrome. Journal of Cardiovascular
Pharmacology, 59(3): 249-253.
Black, J.M., Kruger, R., Roberts, R., Lehloenya, R. and
Mendelson, M. 2012. Acute generalised exanthematous
pustulosis secondary to cotrimoxazole or tenofovir.
Southern African Journal of HIV medicine, 13(4): 198-200.
Bleecker, E., Bateman, E.D., Busse, W., Woodcock, A., Frith,
L., House, K.W., Jacques, L., Davis, A.M., Haumann, B. and
Lotvall, J. 2012. Once-daily fluticasone furoate is efficacious
in patients with symptomatic asthma on low-dose inhaled
corticosteroids. Annals of Allergy Asthma & Immunology,
109(5): 353-358.
Blom, D. 2012. Statin therapy for the octogenarian? Journal
of Endocrinology, Metabolism and Diabetes of South
Africa (JEMDSA), 17(1): 37-42.
Bloom, C., Graham, C.M., Berry, M.P.R., Wilkinson, K., Oni,
T., Rozakeas, F., Xu, Z., Rossello-Urgell, J., Chaussabel,
D., Banchereau, J., Pascual, V., Lipman, C.I., Wilkinson,
R.J. and O’ Garra, A. 2012. Detectable changes in
the bloodtransriptome are present after two weeks of
antituberculosis therapy. PLoS One, 7(10): e46191.